Member Info for BuenaVista

Wyndbum, I will only humour your ignorant drivel once.

You know these are terminally ill patients?

You know these are patients with locally advanced or metastasized cancer?

You know that these patients have been dosed at various dosing levels?

You know that people are different?

Thanks eggy. I think you've covered all of TW's talking points there.

Cj, what are the few errors?

wyndbum, do you know what 'pretreated' means for a Phase 1 oncology trial?

Yeah, but your opinion isn't worth anything.

Keep betting on your kaleidoscope game MT.😂

Well, this is what I was expecting — a poster with the 'latest' data. I just find it really weird that what goes into the literature as an historical record of faridox in SGC as of May 2026 is just that abstract with out-of-date data.🤷🏻‍♂️

Oh I don't know. It's quite endearing how he twitters on with TW's twaddle at 10p a time even though he knows it's rubbish and everyone's laughing at him.

Thanks eggy

TokenOfDoom, I didn't suggest Avacta was presenting a poster you absolute piece of dog excrement. I asked if there was a listing of those that ARE presenting posters.

The closer we get to whenever it may be that Avacta presents "updated" data at ASCO, the more I'm reminded about what it was like when Avacta 'presented' at ASCO before and what a dog of a black box that conference is.

...Please provide a link to the page on the ASCO 2026 website where the posters that will be presented are listed.

Please, please, please preface the post with the prompt employed and preferably also the AI engine used if you have asked for an interpretation rather just some straight factual (encyclopaedia-style) information.

Not salivary gland cancer. See the other thread or here: https://www.lse.co.uk/profiles/BuenaVista/

"Head and neck cancer is the sixth most common cancer worldwide, and it affects around 12,800 people in the UK each year."

Is this true? Even if it is true, 'head and neck cancer' is a broader categorisation than salivary gland cancer. However, actually...

The condition treated in the OrigAMI-4 Phase 1/2 trial is Squamous Cell Carcinoma of Head and Neck:: https://clinicaltrials.gov/study/NCT06385080

AI slop on the conditon's name: "Head and neck squamous cell carcinoma (HNSCC) is a common cancer originating in the squamous cells that line the moist, mucosal surfaces of the mouth, throat, and voice box. It is heavily linked to tobacco use, heavy alcohol consumption, and Human Papillomavirus (HPV) infection.

Common Locations - HNSCC is classified by where it develops:

• Oral Cavity: The lips, tongue, gums, and inside of the cheeks.

• Oropharynx: The tonsils, soft palate, and base of the tongue.

• Larynx & Hypopharynx: The voice box and the lower part of the throat.

• Nasopharynx: The area behind the nose."

- - - - -

Well eggy will be so very disappointed because —Warning! AI slop incoming!: "Salivary gland cancer is classified as a type of head and neck cancer, but it is typically not a head and neck squamous cell carcinoma."

So, panic over chaps. The Ribena story continues intact.

Basically it's Schrȫdinger's chat

FOMO kicking in?

Can Avacta be traded on the US OTC market (AVCTF) after UK hours? That market is open until normal NYSE closing time of 4pm, 9pm UK time. It's a thin market but would be worth Americans using if there was news issued via RNS post-UK closing time that was going to lead to a re-rating when AIM reopened.

I understand now that medical conferences are different from preclinical conferences in that in preclinical you do a bit of research and then report the findings whereas in medical you take the latest data cut off point in your trial and summarise the findings so far. What I don't understand is the publishing of this abstract of old data ...and then what? Does the latest cut off data get presented as a poster or as an oral presentation? What public record of the presentation is published, if any, and where? I think 99.99% of the investing world has no idea that Avacta will be presenting updated data within the next few days and that's only slightly less of an idea than we have.

Lay off the glue mate

Thanks gracie. Live and learn!

Looks quite a random arrangement with each page being a separate reverse-chronological list, each starting from now.

Didn't see wyndbum there. Reciprocating!